The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1567
ISSUE1567
March 11, 2019
Rifamycin (Aemcolo) for Treatment of Travelers' Diarrhea
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Rifamycin (Aemcolo) for Treatment of Travelers' Diarrhea
March 11, 2019 (Issue: 1567)
The FDA has approved rifamycin (Aemcolo – Cosmo/
Aries), a minimally absorbed oral antibiotic, for
treatment of adults with travelers' diarrhea (TD)
caused by noninvasive strains of Escherichia coli. It
is not recommended for treatment of...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.